Extracorporeal Photopheresis
：Cellular Photoimmunotherapy
Publication subTitle ：Cellular Photoimmunotherapy
Author： Hildegard T. Greinix Robert Knobler
Publisher： De Gruyter
Publication year： 2012
E-ISBN: 9783110276138
P-ISBN(Paperback): 9783110275940
Subject： R454.2 light therapy
Language： ENG
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Description
Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn’s disease and diabetes mellitus. Due to its exceptional safety profile ECP has gained wide international acceptance through the efforts of leading clinical investigators. Exciting preclinical data and clinical observations provide insight into the mechanisms of action of ECP and are the basis for further clinical investigations.
Chapter